Sinem Saar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sinem Saar has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Fatmanur Tuğcu-Demiröz
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
8 shared publications - Füsun Acartürk
Gazi University Faculty of Pharmacy, Department of Pharmaceutical Technology, Ankara, Türkiye
3 shared publications - Ayşegül Yıldız
Gazi University, Faculty of Pharmacy, Department of Pharmaceutical Technology
2 shared publications - Beyza Akyüz
GAZİ ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ
2 shared publications - Begum Yurdakok-Dikmen
Ankara University Faculty of Veterinary Medicine in Ankara, 06070, Türkiye
1 shared publication - Emine Yıldırım
Department of Analytical Chemistry, Faculty of Pharmacy, Gazi University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 6 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6)
Development of Eudragit-Based Nanofiber Formulations for Colon-Targeted Delivery of Hydrocortisone in Inflammatory Bowel Disease
Purpose: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder requiring effective localized drug delivery to minimize systemic side effects. This study aimed to develop pH-responsive, Eudragit-based nanofiber formulations for colon-targeted oral delivery of hydrocortisone (HC). Methods: HC-loaded nanofibers were fabricated using the electrospinning technique with Eudragit ® S100 and Eudragit ® L100-55 polymers. Physicochemical characterization was performed using Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FT-IR), X-ray Diffraction (XRD), and Proton Nuclear Magnetic Resonance (¹H-NMR) analyses. Morphology, mechanical properties, contact angle, mucoadhesion, in vitro drug release, and ex vivo permeability were evaluated. Cytotoxicity and anti-inflammatory activity were assessed using RAW 264.7 macrophage cells. Results: XRD and DSC analyses indicated a reduction in the crystalline nature of HC within the nanofiber matrix, suggesting partial amorphization following electrospinning. The optimized formulation (E4) exhibited uniform morphology, suitable mechanical properties, and enhanced mucoadhesion. In vitro release studies demonstrated minimal drug release under gastric conditions (~ 11% at pH 1.2) and increased release at intestinal and colonic pH, confirming pH-responsive behavior. Ex vivo studies showed comparable permeability among formulations. Cell culture studies revealed that the formulations were non-cytotoxic (> 80% cell viability) and and significantly reduced TNF-α expression by approximately 39% at the protein level and showed a comparable reduction at the mRNA level. Conclusion: The developed Eudragit-based nanofiber system, particularly the E4 formulation, demonstrated effective colon-targeted delivery, favorable physicochemical properties, and significant anti-inflammatory activity. These findings indicate that HC-loaded nanofibers represent a promising platform for the localized treatment of IBD.
- 6 June 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 21 (6)
Open AccessDevelopment of Eudragit-Based Nanofiber Formulations for Colon-Targeted Delivery of Hydrocortisone in Inflammatory Bowel Disease
Purpose: Inflammatory bowel disease (IBD) is a chronic inflammatory disorder requiring effective localized drug delivery to minimize systemic side effects. This study aimed to develop pH-responsive, Eudragit-based nanofiber formulations for colon-targeted oral delivery of hydrocortisone (HC). Methods: HC-loaded nanofibers were fabricated using the electrospinning technique with Eudragit ® S100 and Eudragit ® L100-55 polymers. Physicochemical characterization was performed using Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FT-IR), X-ray Diffraction (XRD), and Proton Nuclear Magnetic Resonance (¹H-NMR) analyses. Morphology, mechanical properties, contact angle, mucoadhesion, in vitro drug release, and ex vivo permeability were evaluated. Cytotoxicity and anti-inflammatory activity were assessed using RAW 264.7 macrophage cells. Results: XRD and DSC analyses indicated a reduction in the crystalline nature of HC within the nanofiber matrix, suggesting partial amorphization following electrospinning. The optimized formulation (E4) exhibited uniform morphology, suitable mechanical properties, and enhanced mucoadhesion. In vitro release studies demonstrated minimal drug release under gastric conditions (~ 11% at pH 1.2) and increased release at intestinal and colonic pH, confirming pH-responsive behavior. Ex vivo studies showed comparable permeability among formulations. Cell culture studies revealed that the formulations were non-cytotoxic (> 80% cell viability) and and significantly reduced TNF-α expression by approximately 39% at the protein level and showed a comparable reduction at the mRNA level. Conclusion: The developed Eudragit-based nanofiber system, particularly the E4 formulation, demonstrated effective colon-targeted delivery, favorable physicochemical properties, and significant anti-inflammatory activity. These findings indicate that HC-loaded nanofibers represent a promising platform for the localized treatment of IBD.
- Open Access
- 30 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (6) , 381-392
Development and Optimization of Electrospun Poly(vinyl alcohol) Nanofibers for Vaginal Drug Delivery Using Design of Experiments Approach
Development and Optimization of Electrospun Poly(vinyl alcohol) Nanofibers for Vaginal Drug Delivery Using Design of Experiments Approach - Turkish Journal of Pharmaceutical Sciences
- 30 January 2026
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (6) , 381-392
Open AccessDevelopment and Optimization of Electrospun Poly(vinyl alcohol) Nanofibers for Vaginal Drug Delivery Using Design of Experiments Approach
Development and Optimization of Electrospun Poly(vinyl alcohol) Nanofibers for Vaginal Drug Delivery Using Design of Experiments Approach - Turkish Journal of Pharmaceutical Sciences
- 16 December 2025
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- No. Advanced O,p. 12
DEVELOPMENT AND IN-VITRO EVALUATION OF MUCOADHESIVE BUCCAL NANOFIBER FORMULATIONS FOR USE IN ORAL ULCER TREATMENT
Objective: Oral ulcers are common lesions that negatively affect patients’ quality of life due to pain, inflammation, and discomfort. The aim of this study was to develop and evaluate mucoadhesive nanofiber formulations containing hydrocortisone (HC) for the local treatment of oral ulcers. Material and Method: Different types of Eudragit (E100, S100, L100-55) and polyvinylpyrrolidone (PVP) were used as mucoadhesive polymers. Nanofibers were fabricated using electrospinning system. Nanofibers characterized by differential scanning calorimetry (DSC), mechanical testing, contact angle measurements, and ex vivo mucoadhesion studies for buccal application. Result and Discussion: Nanofibers were successfully produced with electrospinning. Thermal analyses confirmed the HC within the nanofibers. Mechanical and wettability studies showed that the nanofibers had suitable physical properties for buccal application. In ex vivo mucoadhesion tests of the formulations, values were 0.20 ± 0.05, 0.12 ± 0.03, and 0.14 ± 0.01 mJ cm⁻² for E2-HC, L2-HC, and S2-HC, respectively. Mucoadhesion tests demonstrated strong adhesion to the mucosal surface, indicating potential for extended residence time and effective local drug delivery. In vitro release profiles of formulations, HC released 40.26%, 47.87% and 47.03% at 1 h for E2-HC, L2-HC and S2-HC, respectively. The formulations demonstrated sustained release and favorable mucoadhesive strength, indicating potential clinical applicability. Hydrocortisone-loaded buccal electrospun nanofibers showed promise as a novel and effective drug delivery platform in the treatment of oral ulcers.
- 16 December 2025
- Published by Ankara Universitesi Eczacilik Fakultesi Dergisi in Ankara Universitesi Eczacilik Fakultesi Dergisi
- No. Advanced O,p. 12
DEVELOPMENT AND IN-VITRO EVALUATION OF MUCOADHESIVE BUCCAL NANOFIBER FORMULATIONS FOR USE IN ORAL ULCER TREATMENT
Objective: Oral ulcers are common lesions that negatively affect patients’ quality of life due to pain, inflammation, and discomfort. The aim of this study was to develop and evaluate mucoadhesive nanofiber formulations containing hydrocortisone (HC) for the local treatment of oral ulcers. Material and Method: Different types of Eudragit (E100, S100, L100-55) and polyvinylpyrrolidone (PVP) were used as mucoadhesive polymers. Nanofibers were fabricated using electrospinning system. Nanofibers characterized by differential scanning calorimetry (DSC), mechanical testing, contact angle measurements, and ex vivo mucoadhesion studies for buccal application. Result and Discussion: Nanofibers were successfully produced with electrospinning. Thermal analyses confirmed the HC within the nanofibers. Mechanical and wettability studies showed that the nanofibers had suitable physical properties for buccal application. In ex vivo mucoadhesion tests of the formulations, values were 0.20 ± 0.05, 0.12 ± 0.03, and 0.14 ± 0.01 mJ cm⁻² for E2-HC, L2-HC, and S2-HC, respectively. Mucoadhesion tests demonstrated strong adhesion to the mucosal surface, indicating potential for extended residence time and effective local drug delivery. In vitro release profiles of formulations, HC released 40.26%, 47.87% and 47.03% at 1 h for E2-HC, L2-HC and S2-HC, respectively. The formulations demonstrated sustained release and favorable mucoadhesive strength, indicating potential clinical applicability. Hydrocortisone-loaded buccal electrospun nanofibers showed promise as a novel and effective drug delivery platform in the treatment of oral ulcers.
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 587-608
HYDROCORTISONE-LOADED POLYVINYL ALCOHOL-BASED FILMS FOR BUCCAL DELIVERY IN THE TREATMENT OF ORAL APHTHOUS ULCERS
Oral aphthous ulcers are recurrent, painful lesions of the oral mucosa that adversely affect patients' quality of life. Buccal films are crucial to enhance drug retention, achieve sustained therapeutic effect, and ultimately improve clinical outcomes in patients suffering from oral aphthous ulcers. The aim of this study was to develop and evaluate polyvinyl alcohol (PVA)-based buccal film formulations loaded with hydrocortisone (HC) for the local treatment of oral aphthous ulcers. Buccal films were prepared using the solvent casting method. The film formulations were characterized in terms of film thickness, moisture content, and contact angle. Mechanical properties were evaluated by determining tensile strength and elongation at break using a texture analyzer. Thermal behavior was assessed via differential scanning calorimetry (DSC), while chemical interactions were examined using Fourier-transform infrared spectroscopy (FTIR). Mucoadhesive performance was tested ex vivo using cow buccal mucosa, and in vitro drug release studies were conducted using Franz diffusion cells with phosphate buffer (pH 6.8) as the receptor medium. The PVA-based formulation exhibited suitable mechanical strength and high elongation at break. Ex vivo mucoadhesion studies showed that the films demonstrated adequate mucoadhesive properties in cow buccal tissue. In vitro release studies demonstrated a sustained release profile of HC over 8 hours. The findings indicate that PVA-based buccal films are promising candidates for effective localized therapy of oral aphthous ulcers, enhanced patient compliance.
- 30 October 2025
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
- Vol. 50 (3) , 587-608
HYDROCORTISONE-LOADED POLYVINYL ALCOHOL-BASED FILMS FOR BUCCAL DELIVERY IN THE TREATMENT OF ORAL APHTHOUS ULCERS
Oral aphthous ulcers are recurrent, painful lesions of the oral mucosa that adversely affect patients' quality of life. Buccal films are crucial to enhance drug retention, achieve sustained therapeutic effect, and ultimately improve clinical outcomes in patients suffering from oral aphthous ulcers. The aim of this study was to develop and evaluate polyvinyl alcohol (PVA)-based buccal film formulations loaded with hydrocortisone (HC) for the local treatment of oral aphthous ulcers. Buccal films were prepared using the solvent casting method. The film formulations were characterized in terms of film thickness, moisture content, and contact angle. Mechanical properties were evaluated by determining tensile strength and elongation at break using a texture analyzer. Thermal behavior was assessed via differential scanning calorimetry (DSC), while chemical interactions were examined using Fourier-transform infrared spectroscopy (FTIR). Mucoadhesive performance was tested ex vivo using cow buccal mucosa, and in vitro drug release studies were conducted using Franz diffusion cells with phosphate buffer (pH 6.8) as the receptor medium. The PVA-based formulation exhibited suitable mechanical strength and high elongation at break. Ex vivo mucoadhesion studies showed that the films demonstrated adequate mucoadhesive properties in cow buccal tissue. In vitro release studies demonstrated a sustained release profile of HC over 8 hours. The findings indicate that PVA-based buccal films are promising candidates for effective localized therapy of oral aphthous ulcers, enhanced patient compliance.
- 1 September 2025
- Published by Hacettepe University in Hacettepe University Journal of the Faculty of Pharmacy
- Vol. 45 (3) , 245-254
Development of Mucoadhesive Nanofiber Platform Using Eudragit® E100 for Vaginal Application
Electrospun nanofibers represent an excellent alternative to classical vaginal dosage forms due to flexibility, high loading capacity, high mucoadhesive strength and enhanced patient compliance. Eudragit®s, which are synthetic polymers composed of methacrylate monomers, are preferred for vaginal drug delivery. The aim of this study was to develop and evaluate Eudragit®-based nanofiber formulations for vaginal drug delivery. Nanofibers were fabricated using electrospinning. Eudragit® E100 at varying polymer concentrations dissolved in an ethanol:dimethylformamide mixture (7:3, v/v). The polymer solutions were characterized in terms of surface tension, viscosity, and electrical conductivity. Thermal behavior of both the raw polymer and the nanofiber formulations was analyzed using Differential Scanning Calorimetry. Surface wettability was assessed by contact angle measurements using an optical tensiometer. The mechanical strength and mucoadhesive properties of the nanofibers were evaluated using a texture analyzer. The viscosity, surface tension and conductivity of the polymer solutions were found to be suitable for electrospinning. All formulations had hydrophobic properties. Mechanical properties of formulations were increased with increasing polymer concentration. Formulation E4 exhibited the highest mucoadhesion value among all tested formulations, clearly demonstrating to adhere to the mucosal surface. It was seen that Eudragit-based formulations may be a potential platform for vaginal application.
- 1 September 2025
- Published by Hacettepe University in Hacettepe University Journal of the Faculty of Pharmacy
- Vol. 45 (3) , 245-254
Development of Mucoadhesive Nanofiber Platform Using Eudragit® E100 for Vaginal Application
Electrospun nanofibers represent an excellent alternative to classical vaginal dosage forms due to flexibility, high loading capacity, high mucoadhesive strength and enhanced patient compliance. Eudragit®s, which are synthetic polymers composed of methacrylate monomers, are preferred for vaginal drug delivery. The aim of this study was to develop and evaluate Eudragit®-based nanofiber formulations for vaginal drug delivery. Nanofibers were fabricated using electrospinning. Eudragit® E100 at varying polymer concentrations dissolved in an ethanol:dimethylformamide mixture (7:3, v/v). The polymer solutions were characterized in terms of surface tension, viscosity, and electrical conductivity. Thermal behavior of both the raw polymer and the nanofiber formulations was analyzed using Differential Scanning Calorimetry. Surface wettability was assessed by contact angle measurements using an optical tensiometer. The mechanical strength and mucoadhesive properties of the nanofibers were evaluated using a texture analyzer. The viscosity, surface tension and conductivity of the polymer solutions were found to be suitable for electrospinning. All formulations had hydrophobic properties. Mechanical properties of formulations were increased with increasing polymer concentration. Formulation E4 exhibited the highest mucoadhesion value among all tested formulations, clearly demonstrating to adhere to the mucosal surface. It was seen that Eudragit-based formulations may be a potential platform for vaginal application.
- Open Access
- 14 May 2025
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (2) , 71-76
Development and Characterization of Mucoadhesive Films Containing Metronidazole for Vaginal Drug Delivery
Development and Characterization of Mucoadhesive Films Containing Metronidazole for Vaginal Drug Delivery - Turkish Journal of Pharmaceutical Sciences
- 14 May 2025
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (2) , 71-76
Open AccessDevelopment and Characterization of Mucoadhesive Films Containing Metronidazole for Vaginal Drug Delivery
Development and Characterization of Mucoadhesive Films Containing Metronidazole for Vaginal Drug Delivery - Turkish Journal of Pharmaceutical Sciences
- 5 April 2023
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Evaluation of Mechanical and Mucoadhesive Properties of Polyvinyl Alcohol Nanofibers As Vaginal Drug Delivery System
Electrospinning is a versatile and inexpensive technique to produce nanofibers. Nanofibers can be a good alternative to classical dosage forms in vaginal applications due to high surface area/volume ratio, high encapsulation efficenciacy and mucoadhesive properties. Polyvinyl alcohol (PVA) is a biocompatible, easily degradable and flexible polymer with mucoadhesive properties used in industrial, commercial and medical applications. The scope of this study is to characterize electropsun nanofibers produced with different PVA types for vaginal use. PVA nanofibers were produced using the electrospinning method. Nanofiber formulations were prepared by dissolving PVA in dimethylformamide (DMF):distilled water (1:1) solvent system. Nanofibers were produced with three different types (PVA M 13/140, PVA G 26/140 and PVA G 40/140) PVA at 5%, 7.5% and 10% concentrations. The surface tension, viscosity and conductivity properties of the polymer mixtures were measured for electrospinning process and these parametres were found suitable for nanofiber production. While the viscosity increased with increasing polymer concentration, the surface tension values were found to be close to each other since the solvent system was the same. The mechanical and the mucoadhesive properties of nanofibers were examined and compared. Mucoadhesive and mechanical properties of nanofiber formulations differed depending on molecular weight and electrospinning process. The nanofiber formulations produced with PVA M 13/140 were found suitable for vaginal applications in terms of their mechanical and mucoadhesive properties. PVA nanofibers can be a good alternative as a drug delivery system in vaginal applications.
- 5 April 2023
- Published by FABAD Farmasotik Bilimler Ankara Dernegi in Fabad Journal of Pharmaceutical Sciences
Evaluation of Mechanical and Mucoadhesive Properties of Polyvinyl Alcohol Nanofibers As Vaginal Drug Delivery System
Electrospinning is a versatile and inexpensive technique to produce nanofibers. Nanofibers can be a good alternative to classical dosage forms in vaginal applications due to high surface area/volume ratio, high encapsulation efficenciacy and mucoadhesive properties. Polyvinyl alcohol (PVA) is a biocompatible, easily degradable and flexible polymer with mucoadhesive properties used in industrial, commercial and medical applications. The scope of this study is to characterize electropsun nanofibers produced with different PVA types for vaginal use. PVA nanofibers were produced using the electrospinning method. Nanofiber formulations were prepared by dissolving PVA in dimethylformamide (DMF):distilled water (1:1) solvent system. Nanofibers were produced with three different types (PVA M 13/140, PVA G 26/140 and PVA G 40/140) PVA at 5%, 7.5% and 10% concentrations. The surface tension, viscosity and conductivity properties of the polymer mixtures were measured for electrospinning process and these parametres were found suitable for nanofiber production. While the viscosity increased with increasing polymer concentration, the surface tension values were found to be close to each other since the solvent system was the same. The mechanical and the mucoadhesive properties of nanofibers were examined and compared. Mucoadhesive and mechanical properties of nanofiber formulations differed depending on molecular weight and electrospinning process. The nanofiber formulations produced with PVA M 13/140 were found suitable for vaginal applications in terms of their mechanical and mucoadhesive properties. PVA nanofibers can be a good alternative as a drug delivery system in vaginal applications.
- 14 January 2022
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 12 (1) , 28-35
Venlafaksin Hidroklorürün Uzatılmış Salım Yapan Tablet Formülasyonlarının Geliştirilmesi ve Değerlendirilmesi
Amaç: Depresyon, 250 milyondan fazla insanı yaştan bağımsız olarak etkileyen mental bozukluktur. Venlafaksin, antidepresan bir ilaçtır ve eski antidepresan ilaçlara göre daha az yan etki ile panik atak ve anksiyete tedavisinde kullanılır. Bununla birlikte, venlafaksin hidroklorür (VH), yeterli plazma-ilaç konsantrasyonunu sağlamak için günde üç kez dozlama gerektiren kısa yarı ömre sahiptir. Bu çalışmanın amacı, günde bir kez verilecek uzun süreli salım yapan VH tabletleri geliştirmektir. Gereç ve Yöntemler: Kontrollü salım ajanı olarak polietilen oksit, sodyum aljinat, hidroksipropil metil selüloz, guar zamkı ve poliakrilik asit kullanıldı. Tabletler doğrudan basım yöntemi ile hazırlandı. Toz (yığın açısı, akış hızı, Carr indeksi ve Hausner oranı) ve tablet (ağırlık homojenliği, sertlik, friabilite) karakterizasyonları değerlendirildi. 24 saat boyunca in vitro salım çalışmaları yapıldı ve ilaç salım kinetikleri farklı modeller kullanılarak değerlendirildi. Bulgular: Guar zamkı ile hazırlanan formülasyon dışında tüm formülasyonlar uygun Carr indeksi ve Hausner oranı gösterdi. Doğrudan basım yöntemi ile üretilen tabletler, ticari tablet ile karşılaştırıldı. Tüm formülasyonlar için uzun süreli VH salımı gözlendi. In vitro salım hızı test sonuçlarına göre, HPMC ve Carbopol polimerlerini içeren F1 formülasyonundan ilaç salımı, ticari tabletlere kıyasla benzer bulunmuştur. Sonuç: Doğrudan basılmış VH tabletler, hasta uyumu ve diğer üretim yöntemlerine kıyasla daha az üretim aşaması ile ticari tabletlere tercih edilebilir bir alternatif olabilir.
- 14 January 2022
- Published by Duzce Universitesi Saglik Bilimleri Enstitusu Dergisi in Sağlık Bilimlerinde Değer
- Vol. 12 (1) , 28-35
Venlafaksin Hidroklorürün Uzatılmış Salım Yapan Tablet Formülasyonlarının Geliştirilmesi ve Değerlendirilmesi
Amaç: Depresyon, 250 milyondan fazla insanı yaştan bağımsız olarak etkileyen mental bozukluktur. Venlafaksin, antidepresan bir ilaçtır ve eski antidepresan ilaçlara göre daha az yan etki ile panik atak ve anksiyete tedavisinde kullanılır. Bununla birlikte, venlafaksin hidroklorür (VH), yeterli plazma-ilaç konsantrasyonunu sağlamak için günde üç kez dozlama gerektiren kısa yarı ömre sahiptir. Bu çalışmanın amacı, günde bir kez verilecek uzun süreli salım yapan VH tabletleri geliştirmektir. Gereç ve Yöntemler: Kontrollü salım ajanı olarak polietilen oksit, sodyum aljinat, hidroksipropil metil selüloz, guar zamkı ve poliakrilik asit kullanıldı. Tabletler doğrudan basım yöntemi ile hazırlandı. Toz (yığın açısı, akış hızı, Carr indeksi ve Hausner oranı) ve tablet (ağırlık homojenliği, sertlik, friabilite) karakterizasyonları değerlendirildi. 24 saat boyunca in vitro salım çalışmaları yapıldı ve ilaç salım kinetikleri farklı modeller kullanılarak değerlendirildi. Bulgular: Guar zamkı ile hazırlanan formülasyon dışında tüm formülasyonlar uygun Carr indeksi ve Hausner oranı gösterdi. Doğrudan basım yöntemi ile üretilen tabletler, ticari tablet ile karşılaştırıldı. Tüm formülasyonlar için uzun süreli VH salımı gözlendi. In vitro salım hızı test sonuçlarına göre, HPMC ve Carbopol polimerlerini içeren F1 formülasyonundan ilaç salımı, ticari tabletlere kıyasla benzer bulunmuştur. Sonuç: Doğrudan basılmış VH tabletler, hasta uyumu ve diğer üretim yöntemlerine kıyasla daha az üretim aşaması ile ticari tabletlere tercih edilebilir bir alternatif olabilir.